Literature DB >> 30159954

Screening and determination for potential acetylcholinesterase inhibitory constituents from ginseng stem-leaf saponins using ultrafiltration (UF)-LC-ESI-MS2.

Yinping Yang1, Xinhe Liang1, Ping Jin1, Na Li1, Qiao Zhang1, Wei Yan2, Hui Zhang1, Jiaming Sun1.   

Abstract

INTRODUCTION: Previous studies have demonstrated that several ginsenosides have remarkable inhibitory effect on acetylcholinesterase (AChE). In the present study, ginseng stem-leaf saponins (GSLS) can improve learning and memory of Alzheimer's disease patients. However, much comprehensive information regarding AChE inhibition of GSLS and its metabolites is yet unknown.
OBJECTIVE: The present study aims to screen and determine the potential of AChE inhibitors (AChEIs) from GSLS.
METHODOLOGY: The active fraction of the GSLS detected in vitro AChE inhibition assays was selected as a starting material for the screening of the potential of AChEIs using ultrafiltration liquid chromatography coupled to electrospray ionisation tandem mass spectrometry (UF-LC-ESI-MS2 ).
RESULTS: The results showed that 31 ginsenosides were identified with analysis using rapid resolution liquid chromatography with a diode array detector combined with electrospray ionisation tandem mass spectrometry (RRLC-DAD-ESI-MS2 ) from the active fraction, and there are 27 compounds with AChE binding activity. Among them, 11 ginsenosides were evaluated and confirmed using in vitro enzymatic assay, and ginsenosides F1 , Rd, Rk3 , 20(S)-Rg3 , F2 and Rb2 were found to possess strong AChE inhibitory activities.
CONCLUSION: The proposed UF-LC-ESI-MS2 method was a powerful tool for the discovery of AChEIs from traditional Chinese medicine (TCM).
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  AChE inhibitor; UF-LC-ESI-MS2; ginseng stem-leaf saponin; ginsenoside

Mesh:

Substances:

Year:  2018        PMID: 30159954     DOI: 10.1002/pca.2787

Source DB:  PubMed          Journal:  Phytochem Anal        ISSN: 0958-0344            Impact factor:   3.373


  4 in total

Review 1.  Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer's Disease.

Authors:  Qin Li; Limor Rubin; Marta Silva; Shuai Li; Chao Yang; Philip Lazarovici; Wenhua Zheng
Journal:  Oxid Med Cell Longev       Date:  2022-06-14       Impact factor: 7.310

Review 2.  Determination of Anti-Alzheimer's Disease Activity of Selected Plant Ingredients.

Authors:  Tomasz Tuzimski; Anna Petruczynik
Journal:  Molecules       Date:  2022-05-18       Impact factor: 4.927

Review 3.  Ginsenoside and Its Therapeutic Potential for Cognitive Impairment.

Authors:  Hui Feng; Mei Xue; Hao Deng; Shiqi Cheng; Yue Hu; Chunxiang Zhou
Journal:  Biomolecules       Date:  2022-09-16

Review 4.  Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences.

Authors:  Jing Li; Qingxia Huang; Jinjin Chen; Hongyu Qi; Jiaqi Liu; Zhaoqiang Chen; Daqing Zhao; Zeyu Wang; Xiangyan Li
Journal:  Front Pharmacol       Date:  2021-06-02       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.